Last Updated on June 22, 2023

Journal for ImmunoTherapy of Cancer- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: BMJ Publishing Group

Abbreviation: J. ImmunoTher. Cancer




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

8.88

SJR

 3.403

h-Index

 100

Rank

 494

Important Details

Title Journal for ImmunoTherapy of Cancer
Standard Abbreviation J. ImmunoTher. Cancer
Type of Publication Journal
Discipline Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)
Impact Score 8.88
SCImago Journal Rank (SJR) 3.403
h-index 100
Overall Rank 494
Publisher Name BMJ Publishing Group
Publication Country United Kingdom
International Standard Serial Number (ISSN) 20511426
Coverage and History 2013-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
14294

About Journal for ImmunoTherapy of Cancer


Journal for ImmunoTherapy of Cancer is a journal published by BMJ Publishing Group. This journal covers the area[s] related to Cancer Research, Immunology, Immunology and Allergy, Molecular Medicine, Oncology, Pharmacology, etc. The coverage history of this journal is as follows: 2013-2022. The rank of this journal is 494. This journal's impact score, h-index, and SJR are 8.88, 100, and 3.403, respectively. The ISSN of this journal is/are as follows: 20511426.

The best quartile of Journal for ImmunoTherapy of Cancer is Q1. This journal has received a total of 14294 citations during the last three years (Preceding 2022).


Journal for ImmunoTherapy of Cancer Impact Score 2022-2023


The latest impact score (IS) of the Journal for ImmunoTherapy of Cancer is 8.88. It is computed in the year 2023 as per its definition and based on Scopus data. 8.88

It is decreased by a factor of around 1.81, and the percentage change is -16.93% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Journal for ImmunoTherapy of Cancer Impact Score 2023


Impact Score 2022 of Journal for ImmunoTherapy of Cancer is 8.88. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Journal for ImmunoTherapy of Cancer. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 8.88
2021 10.69
2020 11.40
2019 9.47
2018 8.00
2017 5.88
2016 5.18
2015 5.03
2014 2.24

Journal for ImmunoTherapy of Cancer h-index


  Table Setting

The h-index of Journal for ImmunoTherapy of Cancer is 100. By definition of the h-index, this journal has at least 100 published articles with more than 100 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Journal for ImmunoTherapy of Cancer ISSN


The International Standard Serial Number (ISSN) of Journal for ImmunoTherapy of Cancer is/are as follows: 20511426.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Journal for ImmunoTherapy of Cancer Ranking and SCImago Journal Rank (SJR)


The Journal for ImmunoTherapy of Cancer is ranked 494 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 3.403.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Journal for ImmunoTherapy of Cancer Publisher


Table Setting

The publisher of Journal for ImmunoTherapy of Cancer is BMJ Publishing Group. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2013-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Journal for ImmunoTherapy of Cancer is J. ImmunoTher. Cancer. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('J. ImmunoTher. Cancer') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Journal for ImmunoTherapy of Cancer


If your area of research or discipline is related to Cancer Research, Immunology, Immunology and Allergy, Molecular Medicine, Oncology, Pharmacology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Journal for ImmunoTherapy of Cancer?

The latest impact score of Journal for ImmunoTherapy of Cancer is 8.88. It is computed in the year 2023.


What is the h-index of Journal for ImmunoTherapy of Cancer?

The latest h-index of Journal for ImmunoTherapy of Cancer is 100. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Journal for ImmunoTherapy of Cancer?

The latest SCImago Journal Rank (SJR) of Journal for ImmunoTherapy of Cancer is 3.403. It is calculated in the year 2023.


What is the ranking of Journal for ImmunoTherapy of Cancer?

The latest ranking of Journal for ImmunoTherapy of Cancer is 494. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Journal for ImmunoTherapy of Cancer?

Journal for ImmunoTherapy of Cancer is published by BMJ Publishing Group. The publication country of this journal is United Kingdom.


What is the abbreviation of Journal for ImmunoTherapy of Cancer?

This standard abbreviation of Journal for ImmunoTherapy of Cancer is J. ImmunoTher. Cancer.


Is "Journal for ImmunoTherapy of Cancer" a Journal, Conference or Book Series?

Journal for ImmunoTherapy of Cancer is a journal published by BMJ Publishing Group.


What is the scope of Journal for ImmunoTherapy of Cancer?

The scope of Journal for ImmunoTherapy of Cancer is as follows:

  • Cancer Research
  • Immunology
  • Immunology and Allergy
  • Molecular Medicine
  • Oncology
  • Pharmacology

For detailed scope of Journal for ImmunoTherapy of Cancer, check the official website of this journal.


What is the ISSN of Journal for ImmunoTherapy of Cancer?

The International Standard Serial Number (ISSN) of Journal for ImmunoTherapy of Cancer is/are as follows: 20511426.


What is the best quartile for Journal for ImmunoTherapy of Cancer?

The best quartile for Journal for ImmunoTherapy of Cancer is Q1.


What is the coverage history of Journal for ImmunoTherapy of Cancer?

The coverage history of Journal for ImmunoTherapy of Cancer is as follows 2013-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Academic Ethics Journal Springer Netherlands 8920 26 2.28
Journal of Field Archaeology Journal Maney Publishing 5639 43 2.38
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division Conference And Proceedings 17477 16 0.00
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings 7015 49 2.14
Journal of Geriatric Physical Therapy Journal Lippincott Williams and Wilkins Ltd. 5578 43 1.80
Journal of International Financial Management and Accounting Journal Wiley-Blackwell Publishing Ltd 6179 42 6.09
Journal of Applied Business Research Journal 23890 29 0.28
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Acta Periodica Technologica Journal University of Novi Sad, Faculty of Technology 19470 18 0.62
Engenharia Agricola Journal Sociedade Brasileira de Engenharia Agricola 15839 30 1.12

Check complete list




Journal for ImmunoTherapy of Cancer Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 8.88
2021 10.69
2020 11.40
2019 9.47
2018 8.00
2017 5.88
2016 5.18
2015 5.03
2014 2.24



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Immunology

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Science immunology
American Association for the Advancement of Science | United States

Nature Immunology
Nature Publishing Group | United Kingdom

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Cell Host and Microbe
Cell Press | United States

Nature Microbiology
Nature Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

Molecular Systems Biology
Wiley-Blackwell | United States

EMBO Journal
Wiley-Blackwell | Germany

Blood
Elsevier BV | United States

Trends in Immunology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Immunology and Allergy

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Immunity
Cell Press | United States

Science immunology
American Association for the Advancement of Science | United States

Nature Immunology
Nature Publishing Group | United Kingdom

Annals of the Rheumatic Diseases
BMJ Publishing Group | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

Trends in Immunology
Elsevier Ltd. | United Kingdom

Lancet Rheumatology, The
Elsevier Ltd. | United Kingdom

Arthritis and Rheumatology
John Wiley and Sons Ltd | United Kingdom

Journal of Allergy and Clinical Immunology
Mosby Inc. | United States

Immunological Reviews
Wiley-Blackwell Publishing Ltd | United Kingdom

Cellular and Molecular Immunology
Nature Publishing Group | United Kingdom

JHEP Reports
Elsevier BV | Netherlands

Mucosal Immunology
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Biomolecular Detection and Quantification
Elsevier GmbH | Germany

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

Pain
Lippincott Williams and Wilkins Ltd. | United States

See All